Our second aim was to determine the mechanism by which Nogo-B may protect vasculature using a hyperglycemic HUVEC model.<h4>Methods</h4>Sera or samples of patients with T2DM and subjects without diabetes were collected from the First or Second Affiliated Hospital of Chongqing Medical University. This evidence concerns the gene RTN4 and type 2 diabetes mellitus.